Frestedt Launches New Training Programs To Augment Clinical Trials!

Frestedt Launches New Training Programs To Augment Clinical Trials!

By Pharma Tech Outlook | Monday, August 19, 2019

Joy Frestedt, President & CEO

The training programs will enable the pharmaceutical sector to meet the demands of creating, running, and monitoring clinical trials in tight timelines and budgets.

FREMONT, CA: The rapid rise of digitalization has seamlessly integrated science with business, enabling organizations to reach new levels.  Especially in the pharmaceutical sector, the tight timelines and budgets of clinical trials demand deep expertise in creating, running, and monitoring them, combined with the development and negotiation of regulatory submissions within a company and with the relevant regulatory authorities around the world.

To impart the critical expertise and knowledge to the next generation of industry professionals, Frestedt recently launched Frestedt Learning Center (FLC), which offers training courses to the public and customized training programs. The center opened its doors to the learners earlier this year, providing them with personalized courses designed for beginner, intermediate, and advanced levels.

The courses offered at FLC include basic good documentation practices (GDP), good clinical practices (GCP), transitioning, medical writing, clinical evaluation reports (CERs), and investigational new drug (IND) applications. The multi-layered curriculum is designed to inculcate the learners with relevant knowledge that will help them in their individual careers.

Frestedt is a consortium of experts working in an innovative, virtual setting to maintain high service quality and optimal cost-effectiveness. The company aims to solve the problems facing the pharmaceutical industry with forward-thinking approaches designed to deliver solutions within the tight timelines and budgets.

The company is focused on providing the right solutions to meet the unique needs of the client, while at the same time, adhering to the highest standards. It assists clients in conducting trials and negotiating with regulatory authorities. It also specializes in the development of quality systems, training sessions, and engineering services designed to secure the success of client products in the US as well as global markets. Frestedt was recently named “2019 Company of the Year” by Pharma Tech Outlook.

"We will continue to support our clients in clinical, regulatory, quality, and engineering affairs and we will assist them in controlling timelines and costs," said Dr. Joy Frestedt, President and CEO, Frestedt in an interview with Pharma Tech Outlook.

Weekly Brief

Read Also